Modern Poisons pp 104-112 | Cite as

The Origins of Regulation



Toxicology textbooks are often structured to focus on one chemical class or another, or on one target tissue or another—a systematic approach that tends to overlook the social and political aspects of toxicology. Yet the story of modern toxicology, beginning immediately after World War II and continuing to the present, is a human-interest story as much as it is a story of polycyclic aromatic hydrocarbons and cancer, or psychoactive drugs and addiction. The next three chapters focus on public recognition of the potential harm caused by anthropogenic chemicals, and the efforts taken by a relatively few individuals to safeguard human health as well as the health of the environment. These key figures shaped contemporary views of chemical regulation, creating an important legacy for today’s toxicologists.


Polycyclic Aromatic Hydrocarbon Diethylene Glycol Clear Cell Adenocarcinoma Anthropogenic Chemical Important Legacy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Botting, J. “The History of Thalidomide.” Drug News & Perspectives 15 (2002): 604–11.CrossRefGoogle Scholar
  2. Gaughan, A. “Harvey Wiley, Theodore Roosevelt, and the Federal Regulation of Food and Drugs.” Student paper, Harvard Law School, 2004. Scholar
  3. Herbst, A. L., D. C. Poskanzer, S. J. Robboy, L. Friedlander, and R. E. Scully. “Prenatal Exposure to Stilbestrol: A Prospective Comparison of Exposed Female Offspring with Unexposed Controls.” New England Journal of Medicine 292 (1975): 334–39.CrossRefGoogle Scholar
  4. Herbst, A. L., H. Ulfelder, and D. C. Poskanzer. “Adenocarcinoma of the Vagina.” New England Journal of Medicine 284 (1971): 878–81.CrossRefGoogle Scholar
  5. Janssen, W. F. “The Story of the Laws behind the Labels.” FDA Consumer. US Food and Drug Administration, 1981. /AboutFDA/WhatWeDo/History/Overviews/ucm056044.htm.Google Scholar
  6. Klimko, K. “FDA’s Contradictory Decisions Related to the Delaney Clause.” Student paper, Harvard Law School, 2011. /urn-3:HUL.InstRepos:8963872.Google Scholar
  7. Neltner, T. G., N. R. Kulkarni, H. M. Alger, M. V. Maffini, E. D. Bongard, N. D. Fortin, and E. D. Olson. “Navigating the U.S. Food Additive Regulatory Program.” Comprehensive Reviews in Food Science and Food Safety 10 (2011): 342–68.CrossRefGoogle Scholar
  8. Nicole, W. “Secret Ingredients: Who Knows What’s in Your Food?” Environmental Health Perspectives 121 (2013): A126–33.CrossRefGoogle Scholar
  9. Quinn, R. “Rethinking Antibiotic Research and Development: World War II and the Penicillin Collaborative.” American Journal of Public Health 103 (2013): 426–34.CrossRefGoogle Scholar
  10. US Food and Drug Administration. “Guidance for Industry: Frequently Asked Questions about GRAS.” US Department of Health and Human Services, 2004. GRASPackaging/ucm061846.htm.Google Scholar
  11. Wax, P. M. “Elixirs, Diluents, and the Passage of the 1938 Federal Food, Drug, and Cosmetic Act.” Annals of Internal Medicine 122 (1995): 456–61.CrossRefGoogle Scholar

Copyright information

© Alan Kolok 2016

Authors and Affiliations

There are no affiliations available

Personalised recommendations